Pharvaris N.V. 4

Insider Robert Glassman exercised 8,000 Pharvaris N.V. stock options at $20.00 and sold 8,000 shares at an average of $37.5495 in a cashless, 10b5-1–planned transaction, ending with 10,500 shares owned.

On September 9, 2026, Pharvaris N.V. insider Robert Glassman exercised 8,000 stock options at $20.00 per share and simultaneously sold 8,000 shares of common stock at a weighted average price of $37.5495 under a Rule 10b5-1 trading plan in a cashless exercise transaction. The option exercise (coded “M”) increased his directly held common shares, and the subsequent sale (coded “S”) monetized the exercised shares, leaving him with 10,500 shares of Pharvaris common stock held directly after the transactions. The stock options, originally priced at $20.00 and expiring February 5, 2031, had vested according to a schedule beginning February 5, 2022, and this Form 4 reflects a scheduled, pre-arranged exercise-and-sale sequence rather than a discretionary open-market trade.

Filing Facts

CIK

1830487

Ticker

PHVS

Form

4

Source Type

fda

Accession

0001193125-26-388909

Alert Tier

6